Showing results (831-840 of 976) with videos related to

Sort By:
Pageof 98
The American Journal of Pathology|December 10, 1998
Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomasH Oka, L Jin, J C Reubi, et al.
Japanese Journal of Cancer Research : Gann|September 30, 2000
Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in ratsJ Ushida, S Sugie, K Kawabata, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 17, 2000
NC100150 Injection, a preparation of optimized iron oxide nanoparticles for positive-contrast MR angiographyK E Kellar, D K Fujii, W H Gunther, et al.
International Archives of Allergy and Immunology|January 1, 1992
Detection of antibodies against streptococcal peptidoglycan and the peptide subunit (synthetic tetra-D-alanyl-bovine serum albumin complex) in rheumatic-diseasesY Todome, H Ohkuni, M Mizuse, et al.
Molecular Psychiatry|May 25, 2016
Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutationsM Kataoka, N Matoba, T Sawada, et al.
Radiation Protection Dosimetry|July 12, 2011
Evaluation of organ doses in CT examinations with an infant anthropomorphic phantomK Fujii, K Akahane, O Miyazaki, et al.
Cancer Gene Therapy|July 6, 2013
The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virusK Fujii, K Kurozumi, T Ichikawa, et al.
The Review of Scientific Instruments|July 22, 2024
Conceptual design of a Doppler spectrometer for 102 m/s cross-field flows in tokamak divertorsK Fujii, R Sano, T Nakano, et al.
Radiation Protection Dosimetry|October 1, 2015
DEVELOPMENT OF AGE-SPECIFIC JAPANESE PHYSICAL PHANTOMS FOR DOSE EVALUATION IN INFANT CT EXAMINATIONSC Yamauchi-Kawaura, K Fujii, K Akahane, et al.
Cancer|May 1, 1999
Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinomaM Ohtani, H Isozaki, K Fujii, et al.
Pageof 98